glp-1 news october 16 2025 Who Gets the Shot? Access by State Alarming rise in weight loss

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)

Oily skin is a common dermatologic concern reported by all types of patients, including those without acne, given its association with larger facial pores and an unclean or greasy appearance (Figure 1)

The capsules and gummies are widely available online without a prescription and promise to help with weight management, cravings and appetite control

Pasotuxizumab, a BiTE immune therapy for castration-resistant prostate cancer: phase I, dose-escalation study findings

Volpe, G

Boosted Confidence: People, especially suffer from peel conditions such as acne and have less self-esteem due to this